Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Dutasteride may help shrink prostate cancer tumors.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Finasteride may reduce prostate tumor cell invasion and spread.

Chestnut flower extract may help reduce prostate cancer growth.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Early hair loss may signal a risk for metabolic syndrome and related health issues.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.